Results 61 to 70 of about 123,186 (155)
International Journal of Microbiology, Volume 2025, Issue 1, 2025.Background: Candida albicans complex species are the main cause of candidiasis. Objectives: The purpose of this study was to report the prevalence and genetic diversity of C. albicans complex using hyphal wall protein 1 (HWP1) gene size polymorphism, as well as the susceptibility patterns to fluconazole and voriconazole.
Soraya Morales-López +6 more
wiley +1 more source
Anticandidal Efficacy of Cinnamon Oil Against Planktonic and Biofilm Cultures of Candida parapsilosis and Candida orthopsilosis [PDF]
, 2011 Candida parapsilosis is yeast capable of forming biofilms on medical devices. Novel approaches for the prevention and eradication of the biofilms are desired.
Pires, Regina Helena [UNESP] +17 more
core +1 more source
mLife, Volume 3, Issue 4, Page 537-550, December 2024.Abstract Glycosylphosphatidylinositol (GPI) anchoring is one of the conserved posttranslational modifications in eukaryotes that attach proteins to the plasma membrane. In fungi, in addition to plasma membrane GPI‐anchored proteins (GPI‐APs), some GPI‐APs are specifically released from the cell membrane, secreted into the cell wall, and covalently ...
Jinbin Hao +6 more
wiley +1 more source
, 2009 Amphotericin B, 5-fluorocytosin, flukonazol, vorikonazol és posakonazol in vitro hatékonysága Candida parapsilosis, Candida orthopsilosis és Candida metapsilosis klinikai izolátumok ellen az idő-ölés görbék alapjángjbiológus - biotechnológusrégi ...
Szilágyi, Mária
core
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida
Mycoses, Volume 67, Issue 11, November 2024.ABSTRACT Background Invasive candidiasis (IC) is increasing due to the rising numbers of immunocompromised patients. Increasing azole resistance rates and daily dosing required for most echinocandins have complicated its treatment. The approval of rezafungin has provided an option for weekly echinocandin treatment.
Marisa L. Winkler +4 more
wiley +1 more source
, 2019 Despite the increasing occurrence of Candida orthopsilosis and Candida metapsilosis in clinical settings, little is known about their microbiological and clinical properties.
Hossein Zarrinfar (7056323) +14 more
core +1 more source
Otolaryngology–Head and Neck Surgery, Volume 171, Issue 1, Page 90-97, July 2024.Abstract Objective This study aims to identify dominant causative pathogens of chronic suppurative otitis media (CSOM) and their antimicrobial susceptibility patterns. The secondary objective is to assess the cholesteatoma concurrence among this population. Study Design A prospective descriptive study.
Tessa K. Suttle +7 more
wiley +1 more source
Ascomycetes yeasts: The hidden part of human microbiome
WIREs Mechanisms of Disease, Volume 16, Issue 3, May/June 2024.The human mycobiota is mainly composed of yeasts of the Ascomycota phylum, across all body sites. There are several factors, both genetic and environmental, that shape the composition of the mycobiota during the human lifetime. Abstract The fungal component of the microbiota, the mycobiota, has been neglected for a long time due to its poor richness ...
Stefano Nenciarini +4 more
wiley +1 more source
, 2019 Aim: In this study, the CRISPR gene-editing approach was used to simultaneously inactivate all three members of the ALS gene family in the opportunistic pathogen Candida orthopsilosis.
Zoppo, Marina +7 more
core +1 more source
, 2010 Candida orthopsilosis and Candida metapsilosis are recently described species phenotypically indistinguishable from Candida parapsilosis . We evaluated phenotyping and molecular methods for the detection of these species among 79 unique blood culture ...
Gahrn-Hansen, Bente +9 more
core +1 more source